Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6834)
All Articles published online
|
Publishing Process of This Article
|
Dec 28, 2017 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Aby ES, Dong TS, Kawamoto J, Pisegna JR, Benhammou JN. Impact of sustained virologic response on chronic kidney disease progression in hepatitis C. World J Hepatol 2017; 9(36): 1352-1360 [PMID: 29359019 DOI: 10.4254/wjh.v9.i36.1352] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v9/i36/1352.htm |
| Number | Citing Articles |
| 1 |
Georgios Neokosmidis, Adonis A. Protopapas, Dimitrios Stogiannou, Athanasios Filippidis, Konstantinos Tziomalos. Cardiometabolic effects of direct-acting antivirals in patients with hepatitis C. Gastroenterología y Hepatología (English Edition) 2023; 46(1): 58 doi: 10.1016/j.gastre.2022.03.008
|
| 2 |
|
| 3 |
Mohamad M. Alkadi, Essa A. Abuhelaiqa, Mostafa F. Elshirbeny, Ahmed F. Hamdi, Omar M. Fituri, Muhammad Asim, Saad R. Alkaabi, Moutaz F. Derbala, Mona E. Jarman, Adel M. Ashour, Awais Nauman, Yousuf K. Al Maslamani, Adeel A. Butt, Hassan A. Al‐Malki. Eradication of hepatitis C virus infection in kidney transplant recipients using direct‐acting antiviral therapy: Qatar experience. Immunity, Inflammation and Disease 2021; 9(1): 246 doi: 10.1002/iid3.386
|
| 4 |
Fabrizio Fabrizi, Roberta Cerutti, Vivek Dixit, Piergiorgio Messa. The impact of antiviral therapy for HCV on kidney disease: a systematic review and meta-analysis. Nefrología 2020; 40(3): 299 doi: 10.1016/j.nefro.2019.07.007
|
| 5 |
Nicola Coppola, Federica Portunato, Antonio Riccardo Buonomo, Laura Staiano, Riccardo Scotto, Biagio Pinchera, Stefania De Pascalis, Daniela Caterina Amoruso, Salvatore Martini, Mariantonietta Pisaturo, Carmine Coppola, Ivan Gentile. Interferon-free regimens improve kidney function in patients with chronic hepatitis C infection. Journal of Nephrology 2019; 32(5): 763 doi: 10.1007/s40620-019-00608-z
|
| 6 |
Fabrizio Fabrizi, Roberta Cerutti, Vivek Dixit, Piergiorgio Messa. The impact of antiviral therapy for HCV on kidney disease: a systematic review and meta-analysis. Nefrología (English Edition) 2020; 40(3): 299 doi: 10.1016/j.nefroe.2020.06.005
|
| 7 |
Andrew C Curnow, Laurence Huang, Margaret A Fischl, Michelle Floris-Moore, Alison Morris, Mehdi Nouraie, Divya B Reddy, Eric C Seaberg, Anandi N Sheth, Phyllis C Tien, Richard J Wang. Hepatitis C Virus Clearance and Diffusing Capacity for Carbon Monoxide in Women With and Without Human Immunodeficiency Virus. Open Forum Infectious Diseases 2024; 11(5) doi: 10.1093/ofid/ofae251
|
| 8 |
Joel Neugarten, Ladan Golestaneh. Chronic Renal Disease. 2020; : 863 doi: 10.1016/B978-0-12-815876-0.00053-X
|
| 9 |
Joan Martínez-Campreciós, Mar Riveiro-Barciela, Raquel Muñoz-Gómez, María-Carlota Londoño, Mercé Roget, Miguel Ángel Serra, Desamparados Escudero-García, Laura Purchades, Manuel Rodríguez, Juan E. Losa-García, María L. Gutiérrez, Isabel Carmona, Javier García-Samaniego, Luís Morano, Ignacio Martín-Granizo, Marta Montero-Alonso, Martín Prieto, Manuel Delgado, Natalia Ramos, María A. Azancot, Francisco Rodríguez-Frías, Maria Buti. Long-term follow-up of HCV-infected patients with end-stage chronic kidney disease after sustained virological response with direct-acting antiviral therapy. Gastroenterología y Hepatología 2023; 46(8): 594 doi: 10.1016/j.gastrohep.2022.12.004
|
| 10 |
Arpan Mohanty, Sarah Salameh, Adeel A. Butt. Impact of Direct Acting Antiviral Agent Therapy upon Extrahepatic Manifestations of Hepatitis C Virus Infection. Current HIV/AIDS Reports 2019; 16(5): 389 doi: 10.1007/s11904-019-00466-1
|
| 11 |
Po-Jen Hsiao, Chia-Jen Hsiao, Fu-Ru Tsai, Yen-Lin Hou, Chih-Chien Chiu, Wen-Fang Chiang, Kun-Lin Wu, Yuan-Kuei Li, Chen Lin, Jenq-Shyong Chan, Chi-Wen Chang, Chi-Ming Chu. From Bench to Bedside: Clinical and Biomedical Investigations on Hepatitis C Virus (HCV) Genotypes and Risk Factors for Albuminuria. Bioengineering 2022; 9(10): 509 doi: 10.3390/bioengineering9100509
|
| 12 |
Joan Martínez-Campreciós, Mar Riveiro-Barciela, Raquel Muñoz-Gómez, María-Carlota Londoño, Mercé Roget, Miguel Ángel Serra, Desamparados Escudero-García, Laura Purchades, Manuel Rodríguez, Juan E. Losa-García, María L. Gutiérrez, Isabel Carmona, Javier García-Samaniego, Luís Morano, Ignacio Martín-Granizo, Marta Montero-Alonso, Martín Prieto, Manuel Delgado, Natalia Ramos, María A. Azancot, Francisco Rodríguez-Frías, Maria Buti. Long-term follow-up of HCV-infected patients with end-stage chronic kidney disease after sustained virological response with direct-acting antiviral therapy. Gastroenterología y Hepatología (English Edition) 2023; 46(8): 594 doi: 10.1016/j.gastre.2022.12.004
|
| 13 |
Kaley Tash, Victor Javier Rivera-Santiago, Jamie P. Morano. Global Virology IV: Viral Disease Diagnosis and Treatment Delivery in the 21st Century. 2024; : 91 doi: 10.1007/978-3-031-57369-9_7
|
| 14 |
Ian A. Strohbehn, Rituvanthikaa Seethapathy, Meghan Lee, Meghan E. Sise. Curative Therapies for Hepatitis C Virus Infection in Patients with Kidney Disease. Kidney360 2021; 2(8): 1316 doi: 10.34067/KID.0001812021
|
| 15 |
Georgios Neokosmidis, Adonis A. Protopapas, Dimitrios Stogiannou, Athanasios Filippidis, Konstantinos Tziomalos. Cardiometabolic effects of direct-acting antivirals in patients with hepatitis C. Gastroenterología y Hepatología 2023; 46(1): 58 doi: 10.1016/j.gastrohep.2022.03.007
|
| 16 |
Giorgio Maria Saracco, Alfredo Marzano, Mario Rizzetto. Therapy of Chronic Viral Hepatitis: The Light at the End of the Tunnel?. Biomedicines 2022; 10(3): 534 doi: 10.3390/biomedicines10030534
|
| 17 |
Dan L. Longo, Patrice Cacoub, David Saadoun. Extrahepatic Manifestations of Chronic HCV Infection. New England Journal of Medicine 2021; 384(11): 1038 doi: 10.1056/NEJMra2033539
|
| 18 |
Safaa R. Askar, Radwa S. Hagag, Moamen A. Ismail, Heba I. Aly. Metabolic syndrome severity z-score in non-diabetic non-obese Egyptian patients with chronic hepatitis c virus infection. Future Journal of Pharmaceutical Sciences 2024; 10(1) doi: 10.1186/s43094-024-00739-6
|
| 19 |
Roberto Minutolo, Maura Ravera, Adamasco Cupisti, Felice Nappi, Marcora Mandreoli, Giorgio Soragna, Pietro Manuel Ferraro, Luca De Nicola. Prevalence of hepatitis C virus infection in non-dialysis CKD patients: a multicentre study in renal clinics. Nephrology Dialysis Transplantation 2021; 36(12): 2348 doi: 10.1093/ndt/gfab190
|
| 20 |
Cheng-Kai Hsu, Tai-Shuan Lai, Yih-Ting Chen, Yi-Ju Tseng, Chin-Chan Lee, Chun-Yu Chen, Heng-Jung Hsu, Heng-Chih Pan, Li-Wei Chen, Cheng-Hung Chien, Chih-Lang Lin, Rong-Nan Chien, I-Wen Wu. Renal function trajectories in hepatitis C infection: differences between renal healthy and chronic kidney disease individuals. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-96782-x
|
| 21 |
Fabrizio FABRIZI, Roberta CERUTTI, Carlo M. ALFIERI, Ezequiel RIDRUEJO. Impact of antiviral therapy with direct acting antiviral agents (DAAs) on kidney disease in patients with chronic hepatitis C. Minerva Gastroenterology 2021; 67(3) doi: 10.23736/S2724-5985.21.02849-X
|
| 22 |
Favian Su, Charles J. Cogan, Ilya Bendich, Ning Zhang, Mary A. Whooley, Alfred C. Kuo. Hepatitis C infection and complication rates after total shoulder arthroplasty in United States veterans. JSES International 2021; 5(4): 699 doi: 10.1016/j.jseint.2021.02.009
|